Greenitio secures USD 1.5M to scale sustainable chitosan-based cosmetics
Greenitio’s recent funding milestone underscores growing investor confidence in sustainable ingredient innovations that address environmental and performance challenges in the beauty industry.
SINGAPORE – Greenitio, a Singapore-based biotech startup, has secured USD 1.5 million in seed funding to scale up its sustainable biopolymer platform based on chitosan derived from mushrooms, targeting the cosmetics and speciality chemicals industries.
This funding round was led by SGInnovate with participation from Better Bite Ventures, Silverstrand Capital, and other investors from the chemicals and cosmetics sectors.
Greenitio focuses on replacing petrochemical and microplastic ingredients with bio-based, biodegradable, and cost-efficient functional biopolymers that enhance performance aspects such as film formation, moisturization, SPF boosting, and anti-inflammatory properties.
The investment will enable Greenitio to move from lab-scale to commercial production, advance regulatory approvals, and expand collaborations with global cosmetics and chemical companies.
Their fungal chitosan-derived biopolymers serve as high-performance, multifunctional ingredients positioned as competitive, more affordable substitutes for both synthetic petrochemicals and natural alternatives in cosmetics, personal care, and home care formulations.
The company is also unlocking the benefits of vegan chitosan, such as biodegradability, reduced supply chain complexity, and multifunctional properties, including sunscreen-boosting and anti-ageing effects, which support a circular economy and meet consumer demand for eco-friendly products.
Greenitio’s recent funding milestone underscores growing investor confidence in sustainable ingredient innovations that address environmental and performance challenges in the beauty industry, positioning the startup at the forefront of the global transition toward cleaner, bio-based cosmetic ingredients.
The company currently operates R&D and pilot production in Singapore and plans to scale industrial output with a toll manufacturer in India, aiming for a production capacity of up to 25 tonnes per month.
In addition, Greenitio is establishing a subsidiary in the Benelux region to facilitate European market growth and partnerships.
Greenitio’s patented green chemistry process notably reduces the carbon footprint by up to 87% compared to conventional chemistries, while offering three times the cost efficiency of comparable bio-based alternatives.
Greenitio creates biodegradable, bio-based substitutes for petrochemical and microplastic ingredients in cosmetics and personal care.
Their patented platform converts natural polymers into materials that improve SPF, texture, and product stability.
These innovations also comply with upcoming EU microplastics regulations, positioning them ahead of the 2027 ban.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
